Company CVAbout Mangalam Drugs and Organics Ltd 
Mangalam Drugs and Organics Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Mangalam Drugs and Organics Limited was initially incorporated as 'Advent Pharma Private Limited' on April 18, 1972. On July 1, 1997, the Company changed the name from Advent Pharma Private Limited to Mangalam Drugs and Organics Private Limited. Thereafter, it converted the status into a Public Limited Company, changing the name to Mangalam Drugs and Organics Limited on August 10, 2001. The company was established to set up a plant for manufacture of organic and inorganic chemicals.
Company Coordinates
Company Details
3rd Floor Rupam Building, 239 P D Mello Road Mumbai Maharashtra : 400001
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai
Capital StructureCapital Structure
Present Equity Capital
INR 15.83 Cr
Number of Shares
1.58 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
09-Jun-2016
1.58
15.83
1450000
10
Conversion of Warrants
16-Nov-2015
1.44
14.38
1200000
10
Conversion of Warrants
15-Nov-2015
1.44
14.38
1200000
10
Conversion of Warrants
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Non Institution
Pledged Promoter Holdings
7.0903
Mutual Funds
Held by 0 Schemes
FIIs
Held by 2 FIIs (0.13%)
Promoter with highest holding
Shree Rasbihari Trading & Investment Pvt Ltd (6.21%)
Highest Public shareholder
Ambika Food Industries Private Limited (1.04%)
Individual Investors Holdings
57.52%
Board of Directors
Management
Designation
Remuneration
Govardhan M Dhoot
Chairman & Managing Director
20.0 lacs
Brijmohan Dhoot
Whole-time Director
6.0 lacs
Rukmesh P. Dhandhania
Independent Director
36.0 k
Nidhi S. Mundada
Independent Director
38.0 k
Praveen Saxena
Independent Director
20.0 k
Jayant Barde
Company Sec. & Compli. Officer
0
Rakesh K. Milwani
Director
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
No Data Available for Finished Goods Segmentation
No Data Available
Stock DNARevenue and Profits:
Net Sales:
58 Cr
(Quarterly Results - Dec 2025)
Net Profit:
-10 Cr
Pharmaceuticals & Biotechnology
INR 47 Cr (Micro Cap)
NA (Loss Making)
31
0.00%
0.72
-15.52%
0.37
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
